| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |